Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoHyperextensible skin

FGD1 ADAMTS2 MLXIPL

3.16e-0516233HP:0000974
HumanPhenoAbnormally lax or hyperextensible skin

FGD1 ADAMTS2 MLXIPL

4.27e-0517933HP:0008067
HumanPhenoHypodontia

FGD1 ADAMTS2 MLXIPL

8.97e-0522933HP:0000668
HumanPhenoAbnormal elasticity of skin

FGD1 ADAMTS2 MLXIPL

1.01e-0423833HP:0010647
HumanPhenoAbnormal lower lip morphology

FGD1 ADAMTS2 MLXIPL

1.06e-0424233HP:0000178
HumanPhenoLarge earlobe

FGD1 MLXIPL

1.53e-043732HP:0009748
HumanPhenoUmbilical hernia

FGD1 ADAMTS2 MLXIPL

2.15e-0430633HP:0001537
HumanPhenoSoft skin

ADAMTS2 MLXIPL

2.18e-044432HP:0000977
HumanPhenoInguinal hernia

FGD1 ADAMTS2 MLXIPL

2.28e-0431233HP:0000023
HumanPhenoAbnormal umbilicus morphology

FGD1 ADAMTS2 MLXIPL

2.30e-0431333HP:0001551
HumanPhenoAbnormality of external features of the abdomen

FGD1 ADAMTS2 MLXIPL

2.60e-0432633HP:0001462
HumanPhenoTooth agenesis

FGD1 ADAMTS2 MLXIPL

3.59e-0436333HP:0009804
HumanPhenoTooth malposition

FGD1 ADAMTS2 MLXIPL

5.49e-0441833HP:0000692
HumanPhenoAbnormal number of teeth

FGD1 ADAMTS2 MLXIPL

5.61e-0442133HP:0006483
HumanPhenoHernia of the abdominal wall

FGD1 ADAMTS2 MLXIPL

9.75e-0450633HP:0004299
HumanPhenoThoracoabdominal wall defect

FGD1 ADAMTS2 MLXIPL

1.00e-0351133HP:0100656
HumanPhenoAbdominal wall defect

FGD1 ADAMTS2 MLXIPL

1.00e-0351133HP:0010866
HumanPhenoJoint hypermobility

FGD1 ADAMTS2 MLXIPL

1.30e-0355733HP:0001382
HumanPhenoAbnormality of the abdominal wall

FGD1 ADAMTS2 MLXIPL

1.32e-0356033HP:0004298
HumanPhenoHernia

FGD1 ADAMTS2 MLXIPL

1.54e-0358933HP:0100790
HumanPhenoEpicanthus

FGD1 ADAMTS2 MLXIPL

1.74e-0361433HP:0000286
HumanPhenoCutis laxa

ADAMTS2 MLXIPL

1.94e-0313132HP:0000973
HumanPhenoAbnormal earlobe morphology

FGD1 MLXIPL

2.12e-0313732HP:0000363
HumanPhenoEverted lower lip vermilion

FGD1 ADAMTS2

2.18e-0313932HP:0000232
PathwayREACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION

FASN MLXIPL

1.27e-058102M26991
PathwayWP_FOXA2_PATHWAY

FASN MLXIPL

9.44e-0521102M42579
Pubmed

Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use.

FASN MLXIPL

1.09e-07212238167725
Pubmed

Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk.

FASN MLXIPL

3.27e-07312219252981
Pubmed

Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.

FASN MLXIPL

3.27e-07312228027934
Pubmed

Targeted deletion of kidney glucose-6 phosphatase leads to nephropathy.

FASN MLXIPL

7.19e-061212224717294
Pubmed

Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring.

FASN MLXIPL

9.91e-061412225249504
Pubmed

Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice.

FASN MLXIPL

9.91e-061412222055502
Pubmed

Adiponectin enhances mouse fetal fat deposition.

FASN MLXIPL

2.07e-052012222872236
Pubmed

Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC).

FASN MLXIPL

2.51e-052212220965718
Pubmed

Perinatal deiodinase 2 expression in hepatocytes defines epigenetic susceptibility to liver steatosis and obesity.

FASN MLXIPL

2.75e-052312226508642
Pubmed

Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.

FASN MLXIPL

2.75e-052312227974211
Pubmed

Gene expression and characterization of clonally derived murine embryonic brown and brite adipocytes.

FASN MLXIPL

4.41e-052912238972757
Pubmed

High glucose mediates the ChREBP/p300 transcriptional complex to activate proapoptotic genes Puma and BAX and contributes to intervertebral disc degeneration.

FASN MLXIPL

4.41e-052912234461288
Pubmed

The conserved Mediator subunit cyclin C (CCNC) is required for brown adipocyte development and lipid accumulation.

FASN MLXIPL

7.22e-053712235863637
InteractionRASGRP4 interactions

FASN BNIP2

2.14e-0512122int:RASGRP4
InteractionDACH2 interactions

FASN GYG2

3.40e-0515122int:DACH2
ToppCellLV-11._Adipocyte|World / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.06e-051661237e5852891714465c6228c9f955fd511ec79d0e02
ToppCellCOVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type

FASN GYG2 MLXIPL

1.12e-05169123bd39f85b48207955f80ca120a11e15a0124117b9
ToppCellmetastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass

ADAMTS2 STYXL2 TTC7B

1.18e-05172123f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCellLV-11._Adipocyte|LV / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.20e-05173123c2d3fcb3de71015d03d14c63450853d2b03ffa71
ToppCellRV-11._Adipocyte|World / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.28e-05177123f0edf04930692418953e4f00a917257804ec0ffd
ToppCellRV-11._Adipocyte|RV / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.30e-05178123278bbea5cf8f0589f71675c7a3d00679391b5253
ToppCellRA-11._Adipocyte|RA / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.35e-05180123d48a3d27357f7d184132a6805950f93080146b59
ToppCellLA-11._Adipocyte|LA / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.42e-051831233f9011976782fa8aa95cdd6f00f07a91094d411b
ToppCellLA-11._Adipocyte|World / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.42e-05183123b177be283e1553fb1f69a346f1ba79ad00297fa2
ToppCellRA-11._Adipocyte|World / Chamber and Cluster_Paper

FASN GYG2 MLXIPL

1.54e-051881234dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCellLPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

GAST GYG2

3.37e-04103122eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

ADAMTS2 GAST

6.57e-041441221c001a5a3bbe4ecbce8305f8b260e933033550dd
ToppCellCOVID-19_Severe-MAIT|World / disease group, cell group and cell class

DCUN1D3 MLXIPL

6.67e-041451228d63f97812f63329ef9c940b291dc5a1c4d90690
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DCUN1D3 GAST

6.94e-04148122fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0
ToppCellCOVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class

DCUN1D3 MLXIPL

7.13e-04150122923ea7ecc0aa05fb0396082cd9c3d1594135f1e0
ToppCellCOVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type

FASN MLXIPL

7.42e-0415312293958bd9c951222ba5b740d1cb83fd5d78a10e1e
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

7.90e-041581229f58428f70d1427b20122c5c1cc7bf521d0f4832
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DCUN1D3 MLXIPL

8.00e-041591222f6c60ddff2208a68146f9786143d9aefd528840
ToppCellBAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DCUN1D3 MLXIPL

8.00e-04159122ded4e3626a62fb6334403b7213b467fb7e8131c3
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

8.10e-04160122c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FASN GYG2

8.20e-04161122a006491c991e6a134be20ad75092a91f3b7c3c91
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FASN GYG2

8.20e-041611224f25eeabb841b0b9204cdd4e71d5e131e7868184
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FASN MLXIPL

8.31e-04162122d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FASN MLXIPL

8.31e-0416212206f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCellBAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters

DCUN1D3 MLXIPL

8.41e-041631227047d3ba847930f42a6d5f71e18d49f3071c6409
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

8.61e-04165122d449a568664a81d9b5538e8f409301448a32ac37
ToppCell5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

8.72e-04166122afba41e15478053f11815acf568d29187de75492
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAFB2 TTC7B

8.82e-04167122528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCell5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

8.82e-04167122720dc5855c856b478b5ca90156b30bfcc5518d60
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SAFB2 TTC7B

8.82e-04167122a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCell3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

8.93e-04168122f3164a85e5630ee8a745c6dba298e1f94ba4d5b8
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

8.93e-04168122073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

8.93e-04168122b98af4043dfa5dfa4413e482879fad88de484675
ToppCelldroplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

9.03e-04169122f195467438c589f87224bde7da720dea072d110c
ToppCelldroplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

9.03e-041691227785cab967a33560830c394c918d6ce625103858
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

FASN MLXIPL

9.14e-041701224ce81608111b9ee7cb974dad2c182f38db3dcd79
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FASN ADAMTS2

9.24e-041711222a77ed79c6f2e700e789c80451a70ecb31639719
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FASN ADAMTS2

9.24e-04171122972fab891135bd755d5526cbc5a963200067b0a6
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.35e-041721222651dece87c3e3d2d6370f5274ebae357474b825
ToppCell3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.46e-0417312246ed379571385684145b5cb6dd4ae340ac546e64
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.57e-04174122019eae059bd9eb107dee8f0d0f574ca36c2c26e1
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.57e-041741223503c7dec498597f76a86dbd5e4bb2311e743bde
ToppCelldroplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FASN MLXIPL

9.68e-041751225c38d4b6c03473d841e6203a7efaa6dcb2d59386
ToppCell3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.79e-04176122d54543510c804474c5c32e007cd699e75fc5aaba
ToppCellpdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

GYG2 MLXIPL

9.79e-041761221e21f80cf0e695ffdd63e4a72cf1e3fa41b60341
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS2 GYG2

9.90e-04177122a25ca82c4bda033ee113f8ecb4a541b22e7a29ca
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS2 GYG2

9.90e-04177122fbead6e56271b1f1d447f89857de444ebe7157b0
ToppCell3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

9.90e-0417712243dce527392f3b8364bb6a55268ce9d6518d3a29
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_MORN2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAMTS2 GYG2

1.00e-03178122b0fc56f583cb3f2977fe2306994c0d478c9a6b1b
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

1.06e-03183122d23018193b9c0806e0d1a9ac15e6392eb8e96aaf
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

1.07e-031841221e6f86f9e379cd9f453f6b7185f681b44eb63e09
ToppCelldroplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ADAMTS2 MLXIPL

1.10e-03187122ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue

ADAMTS2 MLXIPL

1.12e-03188122d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue

ADAMTS2 MLXIPL

1.12e-031881220bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)

ADAMTS2 DCUN1D3

1.14e-03190122e59e3ad044af7b4409d5ecbd326fe83862e5fc9a
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9

ADAMTS2 DCUN1D3

1.15e-0319112280d30d8eedb4c70b58440646325bc04c5700803e
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

FASN MLXIPL

1.16e-0319212206013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GAST MLXIPL

1.16e-031921228df4cfe1461819756138ff1180896238dca2787e
ToppCellsevere_COVID-19|World / disease group, cell group and cell class (v2)

ADAMTS2 TTC7B

1.17e-031931229012cadd138be775fb167a5bc895e512619f8a95
ToppCellLA|World / Chamber and Cluster_Paper

FASN MLXIPL

1.17e-03193122d4bf89437216baf489ea0239136dcedf3b6714af
ToppCellBronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FGD1 ADAMTS2

1.25e-0319912221335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

ADAMTS2 MLXIPL

1.26e-032001223e0041c04e42a47257517dae8707a6454570c256
Drugglycogen

FASN GAST GYG2 MLXIPL

6.18e-05443124CID000439177
Drugbazedoxifene

SAFB2 ADAMTS2

9.55e-0528122CID000154256
DrugOxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A

SAFB2 GYG2 MLXIPL

1.25e-041931233344_UP
DrugICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A

SAFB2 FGD1 GYG2

1.29e-041951231630_UP
Drug5666823; Down 200; 100uM; MCF7; HG-U133A

FGD1 GYG2 MLXIPL

1.29e-04195123609_DN
Druggenistein; Down 200; 1uM; MCF7; HG-U133A

ADAMTS2 GYG2 MLXIPL

1.29e-04195123268_DN
DrugMolsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A

FGD1 GAST GYG2

1.31e-041961232862_UP
DrugTrimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A

FGD1 GAST GYG2

1.31e-041961232876_UP
DrugBromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

GAST GYG2 MLXIPL

1.33e-041971233617_UP
Drugsulindac; Down 200; 100uM; MCF7; HG-U133A

SAFB2 FGD1 GAST

1.33e-04197123168_DN
DrugAtracurium besylate [64228-81-5]; Up 200; 3.2uM; MCF7; HT_HG-U133A

SAFB2 FGD1 GYG2

1.33e-041971231702_UP
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A

FGD1 GAST GYG2

1.37e-041991235604_UP
DrugLY 294002; Up 200; 0.1uM; PC3; HT_HG-U133A

GAST GYG2 MLXIPL

1.39e-042001234440_UP
Drugpropionamide

ADAMTS2 GAST

1.50e-0435122CID000006578
DrugGoserelin

SAFB2 MLXIPL

2.06e-0441122CID000047725
Druglasofoxifene

SAFB2 ADAMTS2

2.38e-0444122CID000216416
Drugundecanal

ADAMTS2 GYG2

2.49e-0445122CID000008186
DrugFatty Acids

FASN MLXIPL

3.72e-0455122ctd:D005227
Drugphenol red

SAFB2 GAST

4.58e-0461122CID000004766
Drug4-aminoazobenzene

ADAMTS2 MLXIPL

5.36e-0466122CID000006051
Drugbeta-lactone

FASN ADAMTS2

8.67e-0484122CID006476006
DrugAC1Q68Z5

FASN GTF2H2 GAST

9.49e-04386123CID000000181
DrugFatty Acids, Omega-3

FASN MLXIPL

1.18e-0398122ctd:D015525
DrugTO-901317

FASN MLXIPL

1.37e-03106122ctd:C423915
Drugbexarotene

ADAMTS2 BNIP2

1.51e-03111122CID000082146
DrugAC1L1A5Z

FASN MLXIPL

1.51e-03111122CID000000850
DiseaseKidney Failure, Chronic

FASN MLXIPL

1.16e-0448102C0022661
Diseasenon-alcoholic fatty liver disease (biomarker_via_orthology)

FASN MLXIPL

2.13e-0465102DOID:0080208 (biomarker_via_orthology)
DiseaseMalignant Neoplasms

FASN DCUN1D3

8.21e-04128102C0006826
Diseasephosphatidylcholine measurement

ADAMTS2 MLXIPL

3.95e-03284102EFO_0010226
Diseasetestosterone measurement

FASN FGD1 MLXIPL

7.69e-031275103EFO_0004908
DiseaseLiver carcinoma

FASN MLXIPL

1.21e-02507102C2239176

Protein segments in the cluster

PeptideGeneStartEntry
DTFVEWEMERRKREG

DCUN1D3

271

Q8IWE4
MGVEWEYRDEDGRET

ADAMTS2

791

O95450
EERRKWEEGRIDYMG

GYG2

471

O15488
EEEEEAYGWMDFGRR

GAST

81

P01350
AEEKEDGRRWRMFRI

BNIP2

121

Q12982
DMVTDDDRRWKAGLY

FASN

31

P49327
MDEEPERTKRWEGGY

GTF2H2C;

1

Q6P1K8
EKRMEEWDRYPRIGD

FGD1

441

P98174
EGNYWKRRIEVVMRE

MLXIPL

166

Q9NP71
MDEEPERTKRWEGGY

GTF2H2

1

Q13888
EGYRRWGREEEKEEE

STYXL2

406

Q5VZP5
RRDDAYWPEGKRVAM

SAFB2

736

Q14151
ELRGSMDEARRWYEE

TTC7B

741

Q86TV6